Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 30, 2015 8:50 AM ET


Company Overview of LiRIS Biomedical, Inc.

Company Overview

LiRIS Biomedical, Inc. operates as a clinical-stage pharmaceutical company. The company develops a portfolio of therapeutics to provide controlled-release of drugs directly to target tissues to treat bladder diseases. The company was founded in 2008 and is based in Lexington, Massachusetts.

99 Hayden Avenue

Suite 100

Lexington, MA 02421

United States

Founded in 2008





Key Executives for LiRIS Biomedical, Inc.

Chief Executive Officer, President and Director
Co-Founder, Scientific Advisor and Director
Age: 55
Co-Founder, Scientific Advisor and Director
Age: 67
Chief Financial Officer
Chief Business Officer and Senior Vice President
Compensation as of Fiscal Year 2015.

LiRIS Biomedical, Inc. Key Developments

TARIS Biomedical LLC Announces Board Appointments

TARIS Biomedical LLC has added Christopher Cutie, M.D., to its senior leadership team as Vice President of Clinical Development, adding to the company’s strong expertise in bladder diseases and drug-device combinations. Dr. Cutie, in addition to over 10 years of experience at Massachusetts General Hospital as a urologic oncologist, also serves as a Global Medical Advisor for Tokai Pharmaceuticals, Inc. and before that, as a physician in residence at Algeta ASA (now Bayer AG). TARIS has also strengthened its board of directors, adding two senior executives who each bring more than 20 years of commercial and management experience in the life sciences industry to the company. Kevin Finney was most recently Vice President and head of Corporate Development at Allergan Inc. He previously held executive management roles at Prometheus Laboratories Inc. (acquired by Nestle Health Science in 2011), Amylin Pharmaceuticals Inc. (acquired by Bristol-Meyers Squibb in 2012) and Parke-Davis division of Warner-Lambert (acquired by Pfizer). Mark Iwicki served most recently as President and Chief Executive Officer at Civitas Therapeutics (acquired by Acorda). Prior to Civitas, he served as President and Chief Executive Officer at Blend Therapeutics and was President and Chief Executive Officer of Sunovion Pharmaceuticals Inc. (formerly Sepracor Inc.). Earlier in his career, Mr. Iwicki was a Senior Vice President and business unit head for multiple therapeutic areas at Novartis Pharmaceuticals. Other TARIS board members include Purnanand Sarma, Ph.D; Ed Kania of Flagship Ventures; Dennis Ausiello, M.D., of Massachusetts General Hospital, and Kevin Bitterman, of Polaris Venture Partners. Rajeev Shah of RA Capital joined as a board observer.

LiRIS Biomedical, Inc. Presents at BIO-Europe 2015, Nov-02-2015

LiRIS Biomedical, Inc. Presents at BIO-Europe 2015, Nov-02-2015 . Venue: Munich, Germany.

Taris Biomedical Inc Presents at BioCentury 22nd Annual Future Leaders in the Biotech Industry Conference, Mar-20-2015

Taris Biomedical Inc Presents at BioCentury 22nd Annual Future Leaders in the Biotech Industry Conference, Mar-20-2015 . Venue: Millennium Broadway Hotel & Conference Center, New York, New York, United States.

Similar Private Companies By Industry

Company Name Region
Chrono Therapeutics Inc. United States
Avecia Biotechnology, Inc. United States
Arteriocyte, Inc. United States
AveXis, Inc. United States
ProstaGene, LLC United States

Recent Private Companies Transactions

Private Placement
October 27, 2015

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact LiRIS Biomedical, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at